CFO Research Results 2019


Findings from Criticaleye's CFO Retreat Research:

  • 71% of CFOs report that stakeholder engagement is becoming more complex and difficult
  • Only 8% are fully confident the senior team can respond to business model disruption
  • 96% of CFOs say their top team is too inward-looking and focused on the short-term
  • 64% say the Chair does not add value in terms of supporting the executive team
  • Building alignment in the senior team is where CFOs say they are falling short

Click here to watch Phil Smith, Chair, Innovate UK (& Criticaleye Board Mentor); Dame Alison Carnwath, Non-executive Director, BP; Vindi Banga, Senior Independent Director, GSK; Mike Evans, Chair, Just Eat; and Tony Hayward, Chair, Glencore share their views on where the CFO is adding value. 

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 218




Legal & General British Land NATS NatWest Group Worldpay Hitachi Solutions Canaccord Genuity Group Inc GlaxoSmithKline plc E.ON UK AlixPartners Lightsource bp Aldermore Group Rolls-Royce LACE Partners Drax Group plc London Stock Exchange Group